Ethyl 5-chloro-3-methylisoxazole-4-carboxylate, 95.0%, 10g

Didodecylamine, 95.0%, 1g

N-(5-BROMOPYRAZIN-2-YL)-2,2-DIMETHYLPROPANAMIDE, 95.0%, 250mg

4,4'-Dibromooctafluorobiphenyl, 97.0%, 25g

(2-Bromo-5-fluoropyridin-3-yl)methanamine hydrochloride, 97%, 1g

2,2,3,3,4,4,5,5-Octafluoro-1,6-hexanediol, 98.0%, 25g

Acetic acid isobutyl ester, min. 99%, for synthesis, 100 ml, glass packaging

1,3-DI-TERT-BUTYL 2-OXOPYRROLIDINE-1,3-DICARBOXYLATE, 95.0%, 2g

(11bR)?-8,?9,?10,?11,?12,?13,?14,?15-?Octahydro-?4-?hydroxy-?2,?6-?bis(2,?4,?6-?trimethylphenyl)?-4-?oxide-dinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphepin, 97%, 1g

Calcium carbonate, min. 98.5%, powder, 2.5 kg, plastic packaging.

3-Bromo-N,N-dimethylpyridin-4-amine, 95.0%, 250mg

(2R,3R,4R,5R)-5-(2-Amino-6-chloro-9H-purin-9-yl)-2-[(4-chlorobenzoyloxy)methyl]-4-fluoro-4-methyloxolan-3-yl 4-chlorobenzoate, 97%, 250mg

5-(4'-Methyl-[1,1'-biphenyl]-4-yl)-1,3,4-thiadiazol-2-amine, 95.0%, 250mg